Anxiety and Depression Association of America

InStride Health Expands in New Jersey to Meet the Need for Insurance-Based Pediatric Anxiety and OCD Treatment

Retrieved on: 
Wednesday, May 17, 2023
Insurance, Systematic review, Depression, Anxiety, OCD, AUC, Child, Suicide, Harvard University, Doctor of Philosophy, Bangladesh Technical Education Board, Harvard Medical School, Anxiety disorder, MD, McLean Hospital, MAMP, ABPP, Anxiety and Depression Association of America, Suicidal ideation, Mental health, Family, Nursing, Health

NEW JERSEY, May 17, 2023 /PRNewswire/ -- InStride Health, an insurance-based provider of evidence-based treatment for children, teens and young adults diagnosed with moderate to severe anxiety and OCD, is now providing behavioral health services in New Jersey.

Key Points: 
  • InStride Health is helping address the pediatric mental health emergency by providing a proven care model to New Jersey children, teens, and young adults diagnosed with moderate to severe anxiety and OCD
    NEW JERSEY, May 17, 2023 /PRNewswire/ -- InStride Health , an insurance-based provider of evidence-based treatment for children, teens and young adults diagnosed with moderate to severe anxiety and OCD, is now providing behavioral health services in New Jersey.
  • InStride's clinical co-founders, Dr. Mona Potter and Dr. Kathryn Boger, PhD, ABPP are both Harvard-trained clinicians who previously co-developed the innovative McLean Anxiety Mastery Program , "MAMP" — a nationally recognized program for the treatment of moderate to severe pediatric anxiety and OCD.
  • According to Advocates for Children of New Jersey , nearly 168,000 New Jersey children, or 10.7%, were struggling with anxiety and depression in 2020.
  • "We started InStride after getting countless calls from families who were not getting what they needed from our mental health system.

Enveric Biosciences Celebrates and Supports 2023 Mental Health Awareness Month

Retrieved on: 
Tuesday, May 2, 2023
Biotechnology, Pharmaceutical, Health, Phobia, Depression, Anxiety, Therapy, Anxiety disorder, Quality of life, Brain, Research, Mental Health Awareness Month, Drug design, Organization, Addiction, Patient, Panic disorder, Social anxiety disorder, Biology, Anxiety and Depression Association of America, Mental health, Pharmaceutical industry, Nursing

Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced its support of Mental Health Awareness Month this May as the company advances its novel development programs to improve the treatment of mental health disorders.

Key Points: 
  • Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced its support of Mental Health Awareness Month this May as the company advances its novel development programs to improve the treatment of mental health disorders.
  • Enveric is developing therapies that target the underlying biology of mental health conditions, with a focus on reducing symptoms and improving patients' overall well-being.
  • Enveric is planning to conduct a multi-cohort, dose-ascending study Phase 1 clinical trial of EB-373 to evaluate the drug’s safety and tolerability.
  • “We are proud to join other leaders and organizations in the mental health community to commemorate May as Mental Health Awareness Month,” said Joseph Tucker, Ph.D., Director and CEO of Enveric Biosciences.

Axsome Therapeutics Joins Mental Health America and the State of New York to Raise Awareness of Mental Health During May is Mental Health Month

Retrieved on: 
Monday, May 1, 2023
Clifford Whittingham Beers, National Alliance, Substance Abuse, 988 Suicide & Crisis Lifeline, DBSA, Central nervous system, Depression, Lifeline, Anxiety, National Alliance on Mental Illness, Prevalence, OCD, Education, DSM-IV codes, Suicide, SAMHSA, Overalls, Quality of life, Substance Abuse and Mental Health Services Administration, Hope, Research, Disorder, CNS, Organization, One World Trade Center, Risk, Mental disorder, Pleasure, ADAA, NAMI, Anxiety and Depression Association of America, Ageing, Health, Therapy, Counselor, Mental health, MHA, Environment, PTSD, Nursing

NEW YORK, May 01, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, is joining Mental Health America (MHA) and the State of New York to raise awareness of mental health during May is Mental Health Month.

Key Points: 
  • NEW YORK, May 01, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, is joining Mental Health America (MHA) and the State of New York to raise awareness of mental health during May is Mental Health Month.
  • In observance of the beginning of May is Mental Health Month, Axsome’s new corporate headquarters, One World Trade Center in New York City, will be lit in green, the color for mental health awareness, on May 1, 2023.
  • Axsome is supporting this year’s MHA ‘look around, look within’ campaign in observance of May is Mental Health Month.
  • Axsome is proud to stand in solidarity with MHA and other national organizations that provide mental health resources to those in need.

Vistagen Presents New Fasedienol (PH94B) Research at 2023 Anxiety and Depression Association of America Conference

Retrieved on: 
Wednesday, April 19, 2023
Research, Mental Health, Medical Supplies, Neurology, Other Health, Biotechnology, General Health, Pharmaceutical, Health, Science, Volunteering, Neuron, Central nervous system, Depression, MOA, Anxiety, SAD, Brain, Cell, CNS, Translational medicine, Anxiety and Depression Association of America, Central nervous system disease, Social anxiety disorder, ADAA, PH94B, Conference, Safety, Pharmaceutical industry

Findings from the study demonstrate local metabolism and clearance of fasedienol from the nasal passages.

Key Points: 
  • Findings from the study demonstrate local metabolism and clearance of fasedienol from the nasal passages.
  • This discovery of the local nasal clearance of fasedienol may explain prior research findings that fasedienol is absent from systemic circulation and from the brain after intranasal administration, contributing to its favorable safety profile in all clinical studies to date, which studies have involved over 30,000 doses of fasedienol administered to adults with SAD.
  • In the study, cells were extracted from the epithelial lining of the dorsal nasal septum of each nasal passage in healthy adult volunteers.
  • Results from incubation of fasedienol with human nasal epithelial cells show that it is progressively metabolized and cleared from the nasal passages by P450-CYP enzymes expressed in nasal epithelial cells, including chemosensory cells, after intranasal spray administration.

Newly Created Free Resource on Childhood Anxiety Helps Pediatric Primary Care Providers and Parents

Retrieved on: 
Tuesday, March 14, 2023
Research, Disorder, Caregiver, Parent, Anxiety and Depression Association of America, Anxiety, MD, Education, Depression, USPSTF, Psychology, Screen, Science, Pediatrics, International Association for Child and Adolescent Psychiatry and Allied Professions, Screen for child anxiety related disorders, ADAA, Friends, PCP, Child, Mental health, PPP, Diagnosis, CDC, Anxiety disorder, Ageing, SCARED, REACH, Nursing

In October 2022, the U.S. Preventative Services Task Force (USPSTF) finalized guidelines recommending that primary care providers (PCPs) screen all children aged 8 to 18 for anxiety disorders.

Key Points: 
  • In October 2022, the U.S. Preventative Services Task Force (USPSTF) finalized guidelines recommending that primary care providers (PCPs) screen all children aged 8 to 18 for anxiety disorders.
  • This new FREE evidence-based resource, created by The REACH Institute and ADAA, can be an extremely useful tool to help primary care providers and parents during a diagnosis and treatment discussion.
  • “We are thrilled to join ADAA in providing this free resource for parents,” said REACH CEO, Dr. Lisa Hunter Romanelli.
  • REACH’s flagship course, Patient-Centered Mental Health in Pediatric Primary Care (PPP), has trained nearly 6,000 pediatric PCPs to date.

"Not Alone" Brings People Together Who May Feel Overwhelmed or Isolated on Christmas and New Year's Day

Retrieved on: 
Monday, December 19, 2022
Health, Women, Seniors, Communications, Social Media, Men, Mental Health, Family, Consumer, Teens, Telemedicine, Virtual Medicine, Holiday, Imagination, Anxiety and Depression Association of America, Anxiety disorder, National Alliance on Mental Illness, Hope, Goby, Anxiety, Mental disorder, Mental health, National Alliance, CST, Medicine, Tourism

First, it was to get well and then to identify tools to stay on the right side of his mental wellness journey.

Key Points: 
  • First, it was to get well and then to identify tools to stay on the right side of his mental wellness journey.
  • What Slough, founder of Goby International , learned is that isolation leads to more challenging mental health problems.
  • “I isolated myself from the people who cared about me most which took me down a dark road.
  • Goby is a community of real people helping one another swim upstream, much like the goby fish swims up mountainous Hawaiian streams.

Psychiatric Times Announces the Addition of the Anxiety and Depression Association of America to its Strategic Alliance Partnership Program

Retrieved on: 
Tuesday, December 6, 2022
Physician, Depression, Quality of life, Disorder, Human, Anxiety, Partnership, ADAA, Anxiety and Depression Association of America, Health, Science, Psychiatry, CME, Medical diagnosis, Knowledge, Education, MJH, PTSD, Patient, Research, OCD, SAP, Mental health, Pharmaceutical industry, Medicine

CRANBURY, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Psychiatric Times™, the #1 psychiatric publication in the United States, today announced that it has added the Anxiety and Depression Association of America (ADAA) to its Strategic Alliance Partnership (SAP) program.

Key Points: 
  • CRANBURY, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Psychiatric Times™, the #1 psychiatric publication in the United States, today announced that it has added the Anxiety and Depression Association of America (ADAA) to its Strategic Alliance Partnership (SAP) program.
  • “The Anxiety and Depression Association of America is proud to partner with MJH and Psychiatric Times™ to further prioritize the care of individuals struggling with depression, anxiety and other disorders,” said Susan Gurley, executive director of ADAA.
  • The Psychiatric Times™ SAP network maximizes partnerships and increases knowledge in leading treatment options designed to improve patient care.
  • As the voice of psychiatry, Psychiatric Times™’ premiere online and in-print content is written by and for mental health care physicians and professionals.

UNIVERSAL MUSIC GROUP LAUNCHES VOTER ENGAGEMENT CAMPAIGNS

Retrieved on: 
Friday, November 4, 2022
Mental health, Foundation, Exercise, Awareness, Student, SVP, Multimedia, Culture, EVP, Anxiety and Depression Association of America, Semantics, Water, Domestic Partner Task Force, Human voice, Universal Music Group, Social responsibility, Legislation, Entrepreneurship, UMG, Transport, University, NAACP, Music, ADAA, Use, Organization, Universal Music Group Nigeria, National Voter Registration Act of 1993, HeadCount, Social media, View, Election, Pachacútec City Special Project, Environment, Depression, Partnership, Election Protection, YMCA, Voto Latino, Democracy, Human, Social justice, Poll, Policy, GLAAD, Association, Task force, Anxiety, Voter Education Project, Program, Solution, Management

SANTA MONICA, Calif., Nov. 4, 2022 /PRNewswire/ -- Universal Music Group (UMG) today announced a voter engagement initiative for the November 2022 U.S. elections spearheaded by its Universal Music All Together Now Foundation and its Task Force for Meaningful Change. The initiative features new and updated installments of the "Use Your Voice" voter registration and education program, as well as the "Pull Up to the Polls" voter transportation components. "Pull Up to the Polls" was devised, and is operated, by UMG's Task Force for Meaningful Change.

Key Points: 
  • SANTA MONICA, Calif., Nov. 4, 2022 /PRNewswire/ --Universal Music Group (UMG) today announced a voter engagement initiative for the November 2022 U.S. elections spearheaded by its Universal Music All Together Now Foundation and its Task Force for Meaningful Change.
  • Student Voter Mobilization Efforts.UMG's creative solutions team, 1824, is supporting student mobilization efforts, including campus voter registration training for college representatives, led by HeadCount.
  • At Universal Music Group, we exist to shape culture through the power of artistry.
  • Universal Music Group's Task Force for Meaningful Change (TFMC) is a group of employee volunteers dedicated to instituting meaningful change.

Catapult Health Adds Anxiety Screening to its VirtualCheckup Solution to Better Assess Hidden Mental Health Issues Impacting the Workforce

Retrieved on: 
Wednesday, November 2, 2022
Professional Services, Public Policy, Government, Mental Health, Health, Telemedicine, Virtual Medicine, Human Resources, Labor, People, Life, Anxiety and Depression Association of America, CEO, Depression, Columbia Suicide Severity Rating Scale, News, Suicidal ideation, Hypertension, Catapult, Degenerative disease, GAD, Diabetes, Workforce, Anxiety, Workplace, ADAA, Multimedia, HR, PHQ, Association, Medicine, Pharmaceutical industry

Employees suffering from mental health issues, such as depression and anxiety, often go unnoticed and untreated.

Key Points: 
  • Employees suffering from mental health issues, such as depression and anxiety, often go unnoticed and untreated.
  • (Photo: Business Wire)
    Addressing mental health issues, such as anxiety, is increasingly key to maintaining workplace productivity.
  • To address this increasing concern, Catapult Health will add screening for generalized anxiety disorder (GAD) to its VirtualCheckup solution in January.
  • The good news is that general anxiety disorder is treatable, said David Michel, CEO for Catapult Health.

The Ross Center Joins ARC Health

Retrieved on: 
Monday, October 24, 2022
Physician, Lists of Palestinian rocket attacks on Israel, American, Culture, The Wall Street Journal, Cognitive behavioral therapy, Smile (Doctor Who), George Washington University School of Medicine & Health Sciences, Health, Patient, Depression, Psychology, Arc Health, Anxiety and Depression Association of America, Partnership, ADAA, Today, The Washington Post, Acquisition, Doctor of Philosophy, DRS, American Psychiatric Association, Association, Anxiety, George Washington University, ARC, Insomnia, Thurston, Psychiatry, PTSD, Beth, OCD, Medicine, Pharmaceutical industry, Medicine, MD

BEACHWOOD, Ohio, Oct. 24, 2022 /PRNewswire/ -- ARC Health, a Thurston Group portfolio company, has announced the acquisition of The Ross Center, a world-class mental health group serving patients in Washington, D.C., Northern Virginia and New York City.

Key Points: 
  • BEACHWOOD, Ohio, Oct. 24, 2022 /PRNewswire/ -- ARC Health, a Thurston Group portfolio company, has announced the acquisition of The Ross Center, a world-class mental health group serving patients in Washington, D.C., Northern Virginia and New York City.
  • Formed in 2021, ARC Health is a mental health specialty services organization supporting psychiatry, psychology, and therapy practice owners in multiple locations throughout the country.
  • The Ross Center co-partner and Clinical Director Greta Hirsch, PhD, PMH-C, explained they are looking forward to the partnership with ARC Health.
  • The Ross Center expands ARC Health's footprint into the New York and DC metropolitan areas key geographies for the fast-growing Mental Health Services Organization, noted Vincent Morra, ARC Health CEO.